Key facts
- This page summarizes Xichen Lin's Form 4 filing for Structure Therapeutics Inc. (GPCR).
- 6 reported transactions and 4 derivative rows are listed below.
- Filing timestamp: 05 Jun 2024, 19:38.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options Exercise
Conversion of derivative security
Options Exercise
Conversion of derivative security
Sale
Sale
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. |
| F2 | 1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. |
| F3 | This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares. |
| F4 | Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. |
| F5 | 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares. |
| F6 | The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. |
| F7 | The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |